Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
211 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Centro Medico Dr. Doreski- Fundacion Respirar
Buenos Aires, Argentina
Recruiting - Hospital Britanico de Buenos Aires
Buenos Aires, Argentina
Recruiting - Organización Médica de Investigación (omi)
Buenos Aires, Argentina
Recruiting - Instituto de Investigaciones Clinicas de Cordoba
Córdoba, Argentina
Recruiting - Breast Clinica de la Mama
La Plata, Argentina
Recruiting - Hospital Provincial del Centenario
Rosario, Argentina
Recruiting - Instituto de Oncología de Rosario
Rosario, Argentina
Recruiting - Centro de Investigaciones Clinicas. Clinica Viedma S.A.
Viedma, Argentina
Recruiting
- St. Vincent'S Hospital Sydney
Darlinghurst, New South Wales, Australia
Recruiting - Lake Macquarie Hospital
Gateshead, New South Wales, Australia
Recruiting - Mater Hospital Sydney
North Sydney, New South Wales, Australia
Recruiting - Sydney Adventist Hospital
Wahroonga, New South Wales, Australia
Recruiting - Monash Health
Clayton, Victoria, Australia
Recruiting - Barwon Health
Geelong, Victoria, Australia
Recruiting - Bayside Health (alfred)
Melbourne, Victoria, Australia
Recruiting - Peter Maccallum Cancer Center
Melbourne, Victoria, Australia
Recruiting - Sunshine Hospital
Saint Albans, Victoria, Australia
Recruiting - Ballarat Oncology & Haematology Clinical Research Fund
Wendouree, Victoria, Australia
Recruiting
- Medical University of Graz
Graz, Austria
Recruiting - Ordensklinikum Linz Gmbh
Linz, Austria
Recruiting - Lkh Feldkirch, Interne E Am Lkh Rankweil
Rankweil, Austria
Recruiting
- Cliniques Universitaires Saint-Luc
Brussels, Belgium
Recruiting - Institut Jules Bordet
Brussels, Belgium
Recruiting - Universitair Ziekenhuis Brussel
Jette, Belgium
Recruiting - Universitair Ziekenhuis Leuven
Leuven, Belgium
Recruiting - Centre Hospitalier de L'Ardenne
Libramont, Belgium
Recruiting - Clinique Chc Mont Legia
Liège, Belgium
Recruiting - Chu-Ucl Namur, Site Sainte-Elisabeth
Namur, Belgium
Recruiting - Vitaz
Sint-Niklaas, Belgium
Recruiting - Chr de Verviers Site Tourelle
Verviers, Belgium
Recruiting
- Oncolinicas Do Brasil Serviços Médicos S.A (oncocentro)
Belo Horizonte, Brazil
Recruiting - Cemec Cto (cpam - Centro de Pesquisas Da Amazônia)
Belém, Brazil
Recruiting - Instituto Do Câncer Do Ceará
Fortaleza, Brazil
Recruiting - Hospital de Cancer Araujo Jorge/ Associacao de Combate Ao Cancer Em Goias
Goiânia, Brazil
Recruiting - Oncoclinicas Natal- Centro de Pesquisa Oncology Natal
Natal, Brazil
Recruiting - Associação Hospitalar Moinhos de Vento
Porto Alegre, Brazil
Recruiting - Centro Gaúcho Integrado - Hospital Mae de Deus
Porto Alegre, Brazil
Recruiting - Irmandade Da Santa Casa de Misericórdia de Porto Alegre
Porto Alegre, Brazil
Recruiting - Uniao Brasileira de Educacao E Assistencia/ Hospital Sao Lucas Da Pucrs
Porto Alegre, Brazil
Recruiting - Instituto de Educação Pesquisa E Gestão Em Saúde
Rio de Janeiro, Brazil
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Aug 2025
- Primary completion
- 30 Apr 2028
- Completion
- 31 Dec 2031
- Last update posted
- 8 Jul 2026
- Registered enrollment
- 540
- Registry id
- NCT06982521
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.